Cognitive Impairment Associated with Mild to Moderate Migraine Episodes: Possible Effects on Workplace Attendance

• by Yoji Yamaguchi, Masaaki Kohta, Kenji Ishikawa, Yasuo Naito, Michio Yamaguchi, Yusuke Ikeuchi, Hiroyasu Shose, Kazuhiro Tanaka, Atsushi Fujita, Takashi Sasayama

• March 4, 2026

CGRP Therapies May Reduce Migraine Days

Systematic review found high-certainty evidence for several calcitonin gene–related peptide–targeted therapies.

• by Andrea Surnit

• May 20, 2026

• 3 min

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min

Researchers Propose TMD Definition for GBD

Consensus description may support inclusion in Global Burden of Disease estimates.

• by Kathryn Wighton

• March 23, 2026

• 3 min